SUMMARY Forty-seven patients with traumatic olecranon bursitis were evaluated after a mean follow-up of 31 months (range 6 to 62 months). Twenty-two patients treated with bursal aspiration had delayed recovery and no complications of therapy. Twenty-five patients treated with intrabursal injection of 20 mg of triamcinolone hexacetonide had rapid recovery, usually within one week, but suffered complications such as infection (3 cases), skin atrophy (5 cases), and chronic local pain (7 cases). Since spontaneous resolution can be expected, a conservative approach is suggested in the treatment of traumatic olecranon bursitis.
While the clinical' and radiological2 findings in traumatic olecranon bursitis have been described in detail, the clinical course and long-term results of therapy remain largely unknown.
We report here the outcome of treatment of 47 consecutive patients with traumatic olecranon bursitis treated with bursal aspiration alone or aspiration followed by corticosteroid injection.
Patients and methods
Sixty male patients with traumatic olecranon bursitis were studied at the Rheumatology Section of the Boston Veterans Adminstration Medical Center from 1 A follow-up survey was conducted by one of the authors (PSW), who was unaware of the elbow originally involved and the treatment used. The mean follow-up period was 31 months with a range of 6 to 62 months.
Results

PATI ENTS
Final data were obtained for 49 (82%) of the original 60 patients; 42 were examined and 7 were questioned by telephone. Two of these patients had undergone bursectomy and will not further be considered here. Of the remaining 11 patients 4 had died of unrelated disease and 7 could not be located.
Twenty-two patients (group I) had been given no therapy beyond a single bursal aspiration; 25 (group II) had received intrabursal triamcinolone hexacetonide at a mean interval of 7 days following initial aspiration. Age, duration of symptoms, and bursal fluid findings were similar in the 2 groups (Table 1) .
RESPONSE TO TREATMENT
In group I, treated by aspiration alone, the percentage of patients with bursal effusion slowly declined over the entire period of observation ( Fig. 1) . In contrast there was a marked and abrupt reduction in the percentage of group II patients with effusion one week following steroid injection. Except for one Skin atrophy, which was defined as thinning and discolouration of the skin overlying the olecranon process (Fig. 2) Ours is a retrospective survey of patients treated by aspiration alone or by aspiration plus local corticosteroid. Decisions on treatment were not random. In spite of these shortcomings the lack of published data on this condition led us to report our experience of 47 patients with traumatic bursitis.
There was a clear difference between the patients treated by aspiration alone and the patients who also received corticosteroids, as depicted by life table analysis. Since an average of 7 days elapsed between initial aspiration and corticosteroid injection, the 2 groups of patients are not strictly comparable. However, this 7-day period would not account for thp difference in shape between the 2 curves in Fig. 1 We conclude from our survey that, while local corticosteroid is an effective treatment for traumatic olecranon bursitis, the high incidence of side effects and the self-limiting nature of the condition indicate conservative therapy for most patients.
A prospective trial with lower doses of corticosteroids is warranted. 
